Development and validation of UV spectrophotometric method for the determination of etoricoxib in bulk and tablet formulation

Rasayan Journal of Chemistry

Volumn 1, Issue 2, 2008, Pages 390-394

  Shahi, S R ^a   Agrawal, G R ^a   Rathi, P B ^a   Shinde, N V ^a   Somani, V G ^a   Mahamuni, S B ^a   Padalkar, A N ^a  

^a GOVERNMENT COLLEGE OF PHARMACY   (India)

Author keywords

Etoricoxib; SUPAC guidelines; Tablet dosage form; UV determination

Indexed keywords

EID: 70449113492     PISSN: 09741496     EISSN: 09760083     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. N. G. B. Agrawal and A. G. Porras, J Clin Pharmacol., 41, 1106-1110 (2001).
2. A. D. Rodrigues, R. A. Halpin, L. A. Geer, et al. Drug Metab Dispos., 31, 224-232(2003).
3. B. Chauhan, S. Shimpi, A. Paradkar, et al. AAPS PharmSciTech, 6 (3), E402-E412 (2005).
4. P. Leclercq, M. G. Malaise, Rev. Med. Liege., 59, 345, (2004).
5. N. V. S. Ramkrishna, K. N. Vishwottam, S. Wishu, et al. J. Chromatography B, 816, 215-221 (2005).
6. Fda. gov. http//fda.gov/SUPAC-IR.
7. R. B. Saudagar, S. Saraf, S. Saraf, et al. Indian J. Pharm. Educ. Res, 41(1), 24-27 (2007).
8. th edition, p. 2748-2751(2005).
9. ICH-Q2R1 Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland (1996).